Report cover image

Remote Patient Monitoring Market By Condition (Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health, Others), By Component (Devices, Software): Global Opportunity Analysis and Industry Forec

Publisher Allied Market Research
Published May 01, 2022
Length 220 Pages
SKU # ALMR17334527

Description

Remote Patient Monitoring Market By Condition (Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health, Others), By Component (Devices, Software): Global Opportunity Analysis and Industry Forecast, 2021-2031

The global remote patient monitoring market was valued $1,866.00 million in 2021 and expected to reach $8,451.41 million by 2031, with a CAGR of 16.3% from 2022 to 2031.

Remote patient monitoring is a subset of telemedicine that uses digital technologies to collect medical and other types of data such as patient’s recovery rate and their prescriptive guidance records about patients outside of the healthcare context. Weight, blood pressure, blood sugar, blood oxygen levels, heart rate, and electrocardiograms are all examples of data that can be transferred to healthcare providers using a telehealth computer system and software that can be loaded on a computer, smartphone, or tablet. remote patient monitoring assists health professionals in monitoring the condition of patients from all over the world ,enhancing the quality of care .

The coronavirus disease (COVID-19) pandemic is one of the major drivers propelling the remote patient monitoring industry. Healthcare providers all over the world are using remote patient monitoring services to monitor patients with moderate COVID-19 symptoms and deliver timely hospital-based care, owing to the virus's highly infectious nature. This helps hospitals free up resources to serve existing and more critical patients. Another significant driver driving remote patient monitoring market expansion is the increase in frequency of cardiovascular disorders, which coincides with the growing elderly population, which is more prone to chronic conditions. Furthermore, as healthcare infrastructure improves and wireless technology advances, as well as smartphone adoption rises, healthcare services are changing from clinic-centric to patient-centric delivery models, such as remote patient monitoring. This is driving the demand for remote patient monitoring systems all across the world. Furthermore, a number of significant players offer remote patient monitoring, which allows for real-time video connection between the patient and the healthcare professional. They're also launching new products that are expected to drive the growth of the market in the future. For example, Dexcom, Inc., a medical device company based in the U.S., recently released the G6 CGM device, which is a compact sensor that checks glucose levels and transmits the data wirelessly to a display device through a transmitter.

The remote patient monitoring market is segmented on the basis of condition, component and region. By condition, the market is fragmented into congestive heart failure, diabetes, chronic obstructive pulmonary disease, blood pressure, mental health and others. By component the market is segregated into devices and software.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major key players that operate in the global remote patient monitoring market are Abott Laboratories, Biotronik SE Co. KG, Boston Scientific Inc., Datos Health, General Electric, Honey Well International, Johnson & Johnson, Koninklijike Philips N.V., Medtronic, and Nihon Kohden.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the remote patient monitoring market analysis from 2021 to 2031 to identify the prevailing remote patient monitoring market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the remote patient monitoring market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global remote patient monitoring market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Condition

Congestive Heart Failure (CHF)
Diabetes
Chronic Obstructive Pulmonary Disease (COPD)
Blood Pressure
Mental Health
Others

By Component

Devices
Software

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Aerotel Medical Systems (1988) Ltd.
Biotronik SE & Co. KG
Boston Scientific Corporation
General Electric Company
Nihon Kohden Corporation
Medtronic Plc
Masimo Corporation
Abbott Laboratories
Johnson and Johnson
Omron Corporation

Table of Contents

220 Pages
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: REMOTE PATIENT MONITORING MARKET, BY CONDITION
4.1 Overview
4.1.1 Market size and forecast
4.2 Congestive Heart Failure (CHF)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Diabetes
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Chronic Obstructive Pulmonary Disease (COPD)
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Blood Pressure
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Mental Health
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Others
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: REMOTE PATIENT MONITORING MARKET, BY COMPONENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Devices
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Software
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: REMOTE PATIENT MONITORING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Condition
6.2.3 North America Market size and forecast, by Component
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Condition
6.2.4.1.2 Market size and forecast, by Component
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Condition
6.2.4.2.2 Market size and forecast, by Component
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Condition
6.2.4.3.2 Market size and forecast, by Component
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Condition
6.3.3 Europe Market size and forecast, by Component
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Condition
6.3.4.1.2 Market size and forecast, by Component
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Condition
6.3.4.2.2 Market size and forecast, by Component
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Condition
6.3.4.3.2 Market size and forecast, by Component
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Condition
6.3.4.4.2 Market size and forecast, by Component
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Condition
6.3.4.5.2 Market size and forecast, by Component
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Condition
6.3.4.6.2 Market size and forecast, by Component
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Condition
6.4.3 Asia-Pacific Market size and forecast, by Component
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Condition
6.4.4.1.2 Market size and forecast, by Component
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Condition
6.4.4.2.2 Market size and forecast, by Component
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Condition
6.4.4.3.2 Market size and forecast, by Component
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Condition
6.4.4.4.2 Market size and forecast, by Component
6.4.4.5 South Korea
6.4.4.5.1 Market size and forecast, by Condition
6.4.4.5.2 Market size and forecast, by Component
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Condition
6.4.4.6.2 Market size and forecast, by Component
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Condition
6.5.3 LAMEA Market size and forecast, by Component
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Condition
6.5.4.1.2 Market size and forecast, by Component
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Condition
6.5.4.2.2 Market size and forecast, by Component
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Condition
6.5.4.3.2 Market size and forecast, by Component
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Condition
6.5.4.4.2 Market size and forecast, by Component
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Aerotel Medical Systems (1988) Ltd.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Biotronik SE & Co. KG
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boston Scientific Corporation
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 General Electric Company
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Nihon Kohden Corporation
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Medtronic Plc
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Masimo Corporation
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Abbott Laboratories
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Johnson and Johnson
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Omron Corporation
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 2. REMOTE PATIENT MONITORING MARKET REVENUE, FOR CONGESTIVE HEART FAILURE (CHF), BY REGION , 2021-2031,($MILLION)
TABLE 3. REMOTE PATIENT MONITORING MARKET FOR CONGESTIVE HEART FAILURE (CHF) BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. REMOTE PATIENT MONITORING MARKET REVENUE, FOR DIABETES, BY REGION , 2021-2031,($MILLION)
TABLE 5. REMOTE PATIENT MONITORING MARKET FOR DIABETES BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. REMOTE PATIENT MONITORING MARKET REVENUE, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION , 2021-2031,($MILLION)
TABLE 7. REMOTE PATIENT MONITORING MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY COUNTRY, 2021-2031,($MILLION)
TABLE 8. REMOTE PATIENT MONITORING MARKET REVENUE, FOR BLOOD PRESSURE, BY REGION , 2021-2031,($MILLION)
TABLE 9. REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE BY COUNTRY, 2021-2031,($MILLION)
TABLE 10. REMOTE PATIENT MONITORING MARKET REVENUE, FOR MENTAL HEALTH, BY REGION , 2021-2031,($MILLION)
TABLE 11. REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH BY COUNTRY, 2021-2031,($MILLION)
TABLE 12. REMOTE PATIENT MONITORING MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
TABLE 13. REMOTE PATIENT MONITORING MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 14. GLOBAL REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 15. REMOTE PATIENT MONITORING MARKET REVENUE, FOR DEVICES, BY REGION , 2021-2031,($MILLION)
TABLE 16. REMOTE PATIENT MONITORING MARKET FOR DEVICES BY COUNTRY, 2021-2031,($MILLION)
TABLE 17. REMOTE PATIENT MONITORING MARKET REVENUE, FOR SOFTWARE, BY REGION , 2021-2031,($MILLION)
TABLE 18. REMOTE PATIENT MONITORING MARKET FOR SOFTWARE BY COUNTRY, 2021-2031,($MILLION)
TABLE 19. REMOTE PATIENT MONITORING MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 20. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 21. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 22. NORTH AMERICA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 23. U.S. REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 24. U.S. REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 25. CANADA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 26. CANADA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 27. MEXICO REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 28. MEXICO REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 29. EUROPE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 30. EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 31. EUROPE REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 32. GERMANY REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 33. GERMANY REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 34. FRANCE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 35. FRANCE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 36. U.K. REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 37. U.K. REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 38. ITALY REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 39. ITALY REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 40. SPAIN REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 41. SPAIN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 42. REST OF EUROPE REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 43. REST OF EUROPE REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 44. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 45. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 46. ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 47. JAPAN REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 48. JAPAN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 49. CHINA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 50. CHINA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 51. AUSTRALIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 52. AUSTRALIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 53. INDIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 54. INDIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 55. SOUTH KOREA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 56. SOUTH KOREA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 57. REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 58. REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 59. LAMEA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 60. LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 61. LAMEA REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 62. BRAZIL REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 63. BRAZIL REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 64. SAUDI ARABIA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 65. SAUDI ARABIA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 66. SOUTH AFRICA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 67. SOUTH AFRICA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 68. REST OF LAMEA REMOTE PATIENT MONITORING MARKET, BY CONDITION, 2021-2031,($MILLION)
TABLE 69. REST OF LAMEA REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2021-2031,($MILLION)
TABLE 70.AEROTEL MEDICAL SYSTEMS (1988) LTD.: COMPANY SNAPSHOT
TABLE 71.AEROTEL MEDICAL SYSTEMS (1988) LTD.: OPERATING SEGMENTS
TABLE 72.AEROTEL MEDICAL SYSTEMS (1988) LTD.: PRODUCT PORTFOLIO
TABLE 73.AEROTEL MEDICAL SYSTEMS (1988) LTD.: NET SALES,
TABLE 74.AEROTEL MEDICAL SYSTEMS (1988) LTD.: KEY STRATERGIES
TABLE 75.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 76.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
TABLE 77.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 78.BIOTRONIK SE & CO. KG: NET SALES,
TABLE 79.BIOTRONIK SE & CO. KG: KEY STRATERGIES
TABLE 80.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 81.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 82.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 83.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 84.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 85.GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 86.GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
TABLE 87.GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 88.GENERAL ELECTRIC COMPANY: NET SALES,
TABLE 89.GENERAL ELECTRIC COMPANY: KEY STRATERGIES
TABLE 90.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 91.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
TABLE 92.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 93.NIHON KOHDEN CORPORATION: NET SALES,
TABLE 94.NIHON KOHDEN CORPORATION: KEY STRATERGIES
TABLE 95.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 96.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 97.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 98.MEDTRONIC PLC: NET SALES,
TABLE 99.MEDTRONIC PLC: KEY STRATERGIES
TABLE 100.MASIMO CORPORATION: COMPANY SNAPSHOT
TABLE 101.MASIMO CORPORATION: OPERATING SEGMENTS
TABLE 102.MASIMO CORPORATION: PRODUCT PORTFOLIO
TABLE 103.MASIMO CORPORATION: NET SALES,
TABLE 104.MASIMO CORPORATION: KEY STRATERGIES
TABLE 105.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 106.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 107.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 108.ABBOTT LABORATORIES: NET SALES,
TABLE 109.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 110.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 111.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 112.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 113.JOHNSON AND JOHNSON: NET SALES,
TABLE 114.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 115.OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 116.OMRON CORPORATION: OPERATING SEGMENTS
TABLE 117.OMRON CORPORATION: PRODUCT PORTFOLIO
TABLE 118.OMRON CORPORATION: NET SALES,
TABLE 119.OMRON CORPORATION: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.REMOTE PATIENT MONITORING MARKET SEGMENTATION
FIGURE 2.REMOTE PATIENT MONITORING MARKET,2021-2031
FIGURE 3.REMOTE PATIENT MONITORING MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.REMOTE PATIENT MONITORING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.REMOTE PATIENT MONITORING MARKET,BY CONDITION,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CONGESTIVE HEART FAILURE (CHF) REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIABETES REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BLOOD PRESSURE REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MENTAL HEALTH REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 19.REMOTE PATIENT MONITORING MARKET,BY COMPONENT,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DEVICES REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SOFTWARE REMOTE PATIENT MONITORING MARKET,2021-2031(%)
FIGURE 22.REMOTE PATIENT MONITORING MARKET BY REGION,2021
FIGURE 23.U.S. REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 24.CANADA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 25.MEXICO REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 26.GERMANY REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 27.FRANCE REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 28.U.K. REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 29.ITALY REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 30.SPAIN REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 31.REST OF EUROPE REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 32.JAPAN REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 33.CHINA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 34.AUSTRALIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 35.INDIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 36.SOUTH KOREA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 37.REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 38.BRAZIL REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 39.SAUDI ARABIA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 40.SOUTH AFRICA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 41.REST OF LAMEA REMOTE PATIENT MONITORING MARKET,2021-2031($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46.COMPETITIVE DASHBOARD
FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 48.AEROTEL MEDICAL SYSTEMS (1988) LTD..: NET SALES ,($MILLION)
FIGURE 49.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
FIGURE 50.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 51.GENERAL ELECTRIC COMPANY.: NET SALES ,($MILLION)
FIGURE 52.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
FIGURE 53.MEDTRONIC PLC.: NET SALES ,($MILLION)
FIGURE 54.MASIMO CORPORATION.: NET SALES ,($MILLION)
FIGURE 55.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 56.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
FIGURE 57.OMRON CORPORATION.: NET SALES ,($MILLION)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us